Everybody has Brugada syndrome until proven otherwise?

Heart Rhythm

Volumn 12, Issue 7, 2015, Pages 1595-1598

  Viskin, Sami ^a   Rosso, Raphael ^a   Friedensohn, Limor ^a   Havakuk, Ofer ^a   Wilde, Arthur A M ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHANNEL BLOCKING AGENT; AJMALINE;

AJMALINE TEST; ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA; BRUGADA SYNDROME; CARDIOVASCULAR RISK; DIAGNOSTIC TEST; ELECTROCARDIOGRAM; FALSE POSITIVE RESULT; HEART ARREST; HEART MUSCLE CONDUCTION SYSTEM; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HIGH RISK PATIENT; HOLTER MONITORING; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; RISK ASSESSMENT; ST SEGMENT ELEVATION; SURVIVOR; CATHETER ABLATION; FEMALE; MALE; PROCEDURES;

AJMALINE; BRUGADA SYNDROME; CATHETER ABLATION; FEMALE; HUMANS; MALE; TACHYCARDIA, ATRIOVENTRICULAR NODAL REENTRY;

EID: 84937400266     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2015.04.017     Document Type: Editorial

References (39)

1. Y. Mizusawa, and A.A. Wilde Brugada syndrome Circ Arrhythm Electrophysiol 5 2012 606 616
2. C. Antzelevitch, P. Brugada, M. Borggrefe, and et al. Brugada syndrome: report of the second consensus conference Heart Rhythm 2 2005 429 440
3. S. Richter, A. Sarkozy, C. Veltmann, and et al. Variability of the diagnostic ECG pattern in an ICD patient population with Brugada syndrome J Cardiovasc Electrophysiol 20 2009 69 75
4. C. Veltmann, T. Papavassiliu, T. Konrad, and et al. Insights into the location of type I ECG in patients with Brugada syndrome: correlation of ECG and cardiovascular magnetic resonance imaging Heart Rhythm 9 2012 414 421
5. K. Shimeno, M. Takagi, K. Maeda, H. Tatsumi, A. Doi, and M. Yoshiyama Usefulness of multichannel Holter ECG recording in the third intercostal space for detecting type 1 Brugada ECG: comparison with repeated 12-lead ECGs J Cardiovasc Electrophysiol 20 2009 1026 1031
6. T. Ikeda, A. Abe, S. Yusu, and et al. The full stomach test as a novel diagnostic technique for identifying patients at risk of Brugada syndrome J Cardiovasc Electrophysiol 17 2006 602 607
7. T. Miyazaki, H. Mitamura, S. Miyoshi, K. Soejima, Y. Aizawa, and S. Ogawa Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome J Am Coll Cardiol 27 1996 1061 1070
8. R. Brugada, J. Brugada, C. Antzelevitch, and et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts Circulation 101 2000 510 515
9. S.G. Priori, A.A. Wilde, M. Horie, and et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013 Heart Rhythm 10 2013 1932 1963
10. V. Probst, C. Veltmann, L. Eckardt, and et al. Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada Syndrome Registry Circulation 121 2010 635 643
11. F. Sacher, V. Probst, P. Maury, and et al. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study, part 2 Circulation 128 2013 1739 1747
12. G. Conte, J. Sieira, G. Ciconte, and et al. Implantable cardioverter-deibrillator therapy in Brugada syndrome: a 20-year single-center experience J Am Coll Cardiol 65 2015 879 888
13. S. Peters, M. Trummel, S. Denecke, and B. Koehler Results of ajmaline testing in patients with arrhythmogenic right ventricular dysplasia-cardiomyopathy Int J Cardiol 95 2004 207 210
14. S. Peters Arrhythmogenic right ventricular dysplasia-cardiomyopathy and provocable coved-type ST-segment elevation in right precordial leads: clues from long-term follow-up Europace 10 2008 816 820
15. P.A. Chiale, H.A. Garro, P.A. Fernandez, and M.V. Elizari High-degree right bundle branch block obscuring the diagnosis of Brugada electrocardiographic pattern Heart Rhythm 9 2012 974 976
16. A. Baranchuk, S. Sicouri, M.V. Elizari, and P.A. Chiale Pause-dependent normalization of ST-segment elevation during the ajmaline test in a patient with Brugada syndrome Heart Rhythm 11 2014 707 709
17. T.B. Newman If almost nothing goes wrong, is almost everything all right? Interpreting small numerators J Am Med Assoc 274 1995 1013
18. M. Govindan, V.N. Batchvarov, H. Raju, and et al. Utility of high and standard right precordial leads during ajmaline testing for the diagnosis of Brugada syndrome Heart 96 2010 1904 1908
19. P.G. Meregalli, J.M. Ruijter, N. Hofman, C.R. Bezzina, A.A. Wilde, and H.L. Tan Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome J Cardiovasc Electrophysiol 17 2006 857 864
20. W. Shimizu, C. Antzelevitch, K. Suyama, and et al. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome J Cardiovasc Electrophysiol 11 2000 1320 1329
21. C. Veltmann, C. Wolpert, F. Sacher, and et al. Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges Europace 11 2009 1345 1352
22. K. Hong, J. Brugada, A. Oliva, and et al. Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations Circulation 110 2004 3023 3027
23. D.G. Altman, and J.M. Bland Diagnostic tests 2: predictive values BMJ 309 1994 102
24. C.R. Bezzina, J. Barc, Y. Mizusawa, and et al. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death Nat Genet 45 2013 1044 1049
25. V. Probst, A.A. Wilde, J. Barc, and et al. SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome Circ Cardiovasc Genet 2 2009 552 557
26. C. Hasdemir, S. Payzin, U. Kocabas, and et al. High prevalence of concealed Brugada syndrome among patients with atrioventricular nodal reentrant tachycardia Heart Rhythm 12 2015 1584 1594
27. M. Gasparini, S.G. Priori, M. Mantica, and et al. Flecainide test in Brugada syndrome: a reproducible but risky tool Pacing Clin Electrophysiol 26 2003 338 341
28. C. Wolpert, C. Echternach, C. Veltmann, and et al. Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome Heart Rhythm 2 2005 254 260
29. N. Hofman, H.L. Tan, M. Alders, and et al. Yield of molecular and clinical testing for arrhythmia syndromes: report of 15 years' experience Circulation 128 2013 1513 1521
30. J.P. Smits, L. Eckardt, V. Probst, and et al. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients J Am Coll Cardiol 40 2002 350 356
31. A.P. Landstrom, and M.J. Ackerman The Achilles' heel of cardiovascular genetic testing: distinguishing pathogenic mutations from background genetic noise Clin Pharmacol Ther 90 2011 496 499
32. L. Eckardt, P. Kirchhof, P. Loh, and et al. Brugada syndrome and supraventricular tachyarrhythmias: a novel association? J Cardiovasc Electrophysiol 12 2001 680 685
33. M.I. Cohen, T.S. Wieand, L.A. Rhodes, and V.L. Vetter Electrophysiologic properties of the atrioventricular node in pediatric patients J Am Coll Cardiol 29 1997 403 407
34. A. Farshidi, M.E. Josephson, and L.N. Horowitz Electrophysiologic characteristics of concealed bypass tracts: clinical and electrocardiographic correlates Am J Cardiol 41 1978 1052 1060
35. P.G. Meregalli, A.A. Wilde, and H.L. Tan Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more? Cardiovasc Res 67 2005 367 378
36. B.J. Boukens, V.M. Christoffels, R. Coronel, and A.F. Moorman Developmental basis for electrophysiological heterogeneity in the ventricular and outflow tract myocardium as a substrate for life-threatening ventricular arrhythmias Circ Res 104 2009 19 31
37. S. Rolf, H.J. Bruns, T. Wichter, and et al. The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol Eur Heart J 24 2003 1104 1112
38. G. Conte, J. Sieira, A. Sarkozy, and et al. Life-threatening ventricular arrhythmias during ajmaline challenge in patients with Brugada syndrome: incidence, clinical features, and prognosis Heart Rhythm 10 2013 1869 1874
39. G. Conte, W. Dewals, J. Sieira, and et al. Drug-induced Brugada syndrome in children: clinical features, device-based management, and long-term follow-up J Am Coll Cardiol 63 2014 2272 2279